One in three cancer drugs get PBAC tick

By Megan Brodie 3 years ago | In Industry, Regulatory
  • 3 years ago

17 May 2021 An academic who spent the past three years examining PBAC cancer submissions…

This is subscriber-only content. Please login to continue reading.